Funny that the multi ID's talk about trial results of competitors in the OM arena (as well as other competitors in other arena trials) and then when IPIX PR's a comparative chart "they" call it "Fluff" again.
Well,how about the PR's that "their" competitors put out regarding their trial results being "Fluff" as well.
Seems only fair.
Kelt
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links